Reformulated OxyContin Drug Found to Induce a Reduction in Addiction, Abuse and Opioid Poisoning

Reformulated OxyContin Drug Found to Induce a Reduction in Addiction, Abuse and Opioid Poisoning
shutterstock_204028162It was recently reported at the American Academy of Pain Medicine's 31st Annual Meeting in National Harbor, Maryland that the reformulated OxyContin® drug resulted in a successful reduction in the diagnosis of addiction, abuse and opioid poisoning among individuals prescribed opioid analgesics, according to a news release. OxyContin (oxycodone HCl extended-release tablets), manufactured by Purdue Pharma L.P., slowly releases the potent opioid oxycodone, which is prescribed to individuals who require a continuous opioid analgesic to manage moderate to severe pain for an extended time period. OxyContin can be prescribed to patients with fibromyalgia, a medical disorder characterized by widespread chronic musculoskeletal pain. OxyContin was originally approved by the U.S. Food & Drug Administration (FDA) in 1995. The reformulated OxyContin with abuse-deterrent properties was designed to help discourage the misuse and abuse of this medication and reduce the risk of overdose and associated deaths. This new formulation is based on a tablet that is harder to manipulate and with physicochemical properties, which is
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *